PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-34.77%
Negative revenue growth while 9698.HK stands at 1.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-21.03%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-10.81%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
16.51%
Net income growth under 50% of 9698.HK's 49.13%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.56%
EPS growth under 50% of 9698.HK's 49.23%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
16.56%
Diluted EPS growth under 50% of 9698.HK's 49.23%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 9698.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.43%
Negative OCF growth while 9698.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-22.18%
Negative FCF growth while 9698.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-32.72%
Negative 10Y revenue/share CAGR while 9698.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-13.73%
Negative 5Y CAGR while 9698.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-41.38%
Negative 3Y CAGR while 9698.HK stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
332.45%
OCF/share CAGR of 332.45% while 9698.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
15.73%
OCF/share CAGR of 15.73% while 9698.HK is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
156.34%
3Y OCF/share CAGR of 156.34% while 9698.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-25.84%
Negative 10Y net income/share CAGR while 9698.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-34.73%
Negative 5Y net income/share CAGR while 9698.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
8.33%
3Y net income/share CAGR of 8.33% while 9698.HK is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
40.38%
Equity/share CAGR of 40.38% while 9698.HK is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
19.50%
Equity/share CAGR of 19.50% while 9698.HK is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-54.66%
Negative near-term dividend growth while 9698.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-21.05%
Firm’s AR is declining while 9698.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
17.16%
Inventory growth of 17.16% while 9698.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-21.04%
Negative asset growth while 9698.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.20%
BV/share growth of 2.20% while 9698.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-38.98%
We’re deleveraging while 9698.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-23.61%
We cut SG&A while 9698.HK invests at 6.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.